Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)

AIDS Research and Human Retroviruses

Volumn 19, Issue 2, 2003, Pages 103-109

  Pido Lopez, Jeffrey ^a   Burton, Catherine ^a   Hardy, Gareth ^a   Pires, Antonio ^a   Sullivan, Ann ^a   Gazzard, Brian ^a   Aspinall, Richard ^a   Gotch, Frances ^a   Imami, Nesrina ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 12; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; T LYMPHOCYTE RECEPTOR; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; THYMUS FUNCTION; TREATMENT OUTCOME;

ADULT; AIDS VACCINES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; GENE REARRANGEMENT, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; THYMUS GLAND;

EID: 0037296497     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203762688603     Document Type: Article

References (30)

1. + T cell homeostasis and function in advanced HIV disease. Science 1997;277:112-116.
2. Pakker NG, Roos MT, van Leeuwen R, de Jong MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, and Schellekens PT: Patterns of T-cell repopulation, virus load reduction, and restoration of T-cell function in HIV-infected persons during therapy with different antiretroviral agents. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:318-326.
3. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, and Hahn BH: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-122.
4. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A, Leonard IM, Danner SA, Miedema F, and Schellekens PT: Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nat Med 1998;4:208-214.
5. McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, and Grant RM: High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998;101:2301-2308.
6. Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, Kuritzkes D, Gross B, Francis I, McCune JM, and Lederman MM: Thymic size and lymphocyte restoration in patients with human immunodeficiency virus injection after 48 weeks of zidovudine, lamivudine and ritonavir therapy. J Infect Dis 2000;181:141-147.
7. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, and Koup RA: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-695.
8. Powderly W, Landay A, and Lederman MM: Recovery of the immune system with antiretroviral therapy. JAMA 1993;280:72-77.
9. Arno A, Ruiz L, Juan M, Jou A, Balague M, Zayat MK, Marfil S, Martinez-Picado J, Martinez MA, Romeu J, Pujol-Borrell R, Lane C, and Clotet B: Efficacy of low dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with <250/μl CD4 T cells and undetectable plasma virus load. J Infect Dis 1999;180:56-60.
10. + T cell proliferation in interleukin-2 treated human immunodeficiency virus positive subjects. Cytometry 2001;46:233-237.
11. Plum J and de Smedt M: Analysis of human prenatal and postnatal thymocytes with anti-TAC monoclonal antibody and recombinant interleukin-2. Thymus 1987;9:149-158.
12. Reya T, Bassiri H, Biancaniello R, and Carding SR: Thymic stromal-cell abnormalities and dysregulated T cell development in IL-2 deficient mice. Dev Immunol 1998;5:287-302.
13. Aspinall R, Pido J, and Andrew D: A simple method for the measurement of sjTREC levels in blood. Mech Ageing Dev 2000;121:59-67.
14. Steffens CM, Smith KY, Landay A, Shott S, Truckenbrod A, Russert M, and Al-Harthi L: T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals. AIDS 2001;13:1757-1764.
15. Chavan S, Bennuri B, Kharbanda M, Chandrasekaran A, Bakshi S, and Pahwa S: Evaluation of T cell receptor gene rearrangement excision circles after antiretroviral therapy in children infected with human immunodeficiency virus. J Infect Dis 2001;183:1445-1454.
16. Douek DC, Koup RA, McFarland RD, Sullivan JL, and Luzuriaga K: Effect of HIV on thymic function before and after antiretroviral therapy in children. J Infect Dis 2000;181:1479-1482.
17. Markert ML, Hicks CB, Bartlett JA, Harmon JL, Hale LP, Greenberg ML, Ferrari G, Ottinger J, Boeck A, Kloster AL, McLaughlin TM, Bleich KB, Ungerleider RM, Lyerly HK, Wilkinson WE, Rousseau FS, Heath-Chiozzi ME, Leonard JM, Haase AT, Shaw GM, Bucy RP, Douek DC, Koup RA, Haynes BF, Bolognesi DP, and Weinhold KJ: Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection. AIDS Res Hum Retroviruses 2000;16:403-413.
18. Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, He Y, Jin X, Tuttleton S, Vesanen M, Spiegel H, Kost R, van Lunzen J, Stellbrink HJ, Wolinsky S, Borkowsky W, Palumbo P, Kostrikis LG, and Ho DD: Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999;190:725-732.
19. Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, Boucher CA, Coutinho RA, Lange JM, Rinke de Wit TF, Tsegaye A, van Dongen JJ, Hamann D, de Boer RJ, and Miedema F: Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000;6:1036-1042.
20. + lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999;103:1391-1398.
21. Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, Markowitz M, Kost R, Hurley A, Weinberger L, Cesar D, Hellerstein MK, and Ho DD: Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med 2001; 194:1277-1287.
22. Grossman Z and Paul WE: The impact of HIV on naive T-cell homeostasis. Nat Med 2000;6:976-977.
23. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, and Orenstein J: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993;178:1151-1163.
24. Withers-Ward ES, Amado RG, Koka PS, Jamieson BD, Kaplan AH, Chen IS, and Zack JA: Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy. Nat Med 1997;3:1102-1109.
25. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-149.
26. Pido Lopez J, Imami N, and Aspinall R: Both age and gender affect thymic output: More recent thymic migrants in females than males as they age. Clin Exp Immunol 2001;125:409-413.
27. Imami N, Hardy GA, Nelson MR, Morris-Jones S, Al-Shahi R, Antonopoulos C, Gazzard B, and Gotch FM: Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy. Clin Exp Immunol 1999;118:78-86.
28. Kovacs J, Lempicki RA, Sidorov IA, et al.: Prolonged and preferential survival of CD4 T lymphocytes in HIV-1 infected patients receiving IL-2 therapy. In 9th Conference on Retroviruses and Opportunistic Infections, February 24-28, 2002 [Abstract 103].
29. 6/L CD4 cell counts: A randomized controlled trial. JAMA 2000;284:2193-2202.
30. Turner JL, Kostman JR, Aquino A, Wright D, Szabo S, Bidwell R, Goodgame J, Daigle A, Kelley E, Jensen F, Duffy C, Carlo D, and Moss RB: The effects of an HIV-1 immunogen (Remune) on viral load, CD4 cell counts and HIV-specific immunity in a double-blind, randomized, adjuvant controlled subset study in HIV infected subjects regardless of concomitant antiviral drugs. HIV Med 2001;2:68-77.